SGEN — Seagen Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareBalancedLarge Cap
- $43.15bn
- $41.92bn
- $1.96bn
Annual cashflow statement for Seagen, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -223 | -159 | 614 | -674 | -610 |
| Depreciation | |||||
| Amortisation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 70.7 | 83.9 | 150 | 197 | 237 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -53.9 | -113 | 42.9 | -88 | -151 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -204 | -164 | 857 | -499 | -454 |
| Capital Expenditures | -21.2 | -70.8 | -82.4 | -52.3 | -77.3 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -571 | -207 | -1,337 | 341 | 306 |
| Acquisition of Business | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -593 | -278 | -1,419 | 289 | 228 |
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | 713 | 638 | 846 | 77.8 | 125 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -82.8 | 196 | 284 | -134 | -101 |